Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.

[1]  O. Yokosuka,et al.  Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute‐onset autoimmune hepatitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[2]  M. Zeniya,et al.  Acute presentation of autoimmune hepatitis: Does it exist? A published work review , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  B. Portmann,et al.  Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis , 2011, Hepatology.

[4]  William M. Lee,et al.  Autoimmune acute liver failure: Proposed clinical and histological criteria , 2011, Hepatology.

[5]  B. Portmann,et al.  Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease , 2009, Hepatology.

[6]  Anurag Maheshwari,et al.  Liver failure as initial presentation of autoimmune hepatitis: Clinical characteristics, predictors of response to steroid therapy, and outcomes , 2009, Hepatology.

[7]  J. Lefkowitch,et al.  Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. , 2008, Liver.

[8]  B. Portmann,et al.  Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  M. Iwai,et al.  Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[11]  D. Vergani,et al.  The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. , 2007, Journal of hepatology.

[12]  A. Montano‐Loza,et al.  Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end‐stage liver disease , 2007, Hepatology.

[13]  A. Burroughs,et al.  Selection of patients for liver transplantation and allocation of donated livers in the UK , 2007, Gut.

[14]  D. Samuel,et al.  Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  B. Portmann,et al.  Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. , 2006, Journal of hepatology.

[16]  Y. Miyake,et al.  Clinical characteristics of fulminant‐type autoimmune hepatitis: an analysis of eleven cases , 2006, Alimentary pharmacology & therapeutics.

[17]  O. Cummings,et al.  Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  F. Chiodo,et al.  Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. , 2004, QJM : monthly journal of the Association of Physicians.

[19]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[20]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[21]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[22]  Roger Williams,et al.  Acute liver failure: redefining the syndromes , 1993, The Lancet.

[23]  G. McCaughan.  Selection of patients for liver transplantation , 1993, Journal of gastroenterology and hepatology.

[24]  R. Koretz,et al.  Chronic active hepatitis , 1980, Digestive Diseases and Sciences.

[25]  W. Maddrey,et al.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy , 1978, The American Journal of Digestive Diseases.

[26]  A. Takaki,et al.  Autoimmune hepatitis with acute presentation in Japan. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.